why choose us

First received: April 03, 2024

Clinical Trial: A Study to Evaluate AMG 133 in Chinese Participants With Obesity or Overweight

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Obesity

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Open-label, Randomized, Parallel-group, Single-dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of AMG 133 Administered Subcutaneously in Chinese Subjects With Obesity

Brief Summary: The main objective of the study is to assess the pharmacokinetics (PK) of Maridebart Cafraglutide after a single subcutaneous (SC) administration in overweight or obese Chinese participants.

Read more